ADMA Biologics Inc vs Diageo plc — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while Diageo plc trades at $93.67 (market cap $53.05B). The key difference: Diageo plc is far larger — about 23.9× ADMA Biologics Inc's market cap, and Diageo plc pays a 3.5% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | DEO | |
|---|---|---|
Market Cap | $2.22B | $53.05B |
Sector | Health | Technology |
52-Week High | $20.38 | $115.33 |
52-Week Low | $7.60 | $72.47 |
Enterprise Value | $2.29B | $72.54B |
Dividend Yield | — | 3.5% |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →